Goldman Sachs
NCIT

Goldman Sachs’s NCI, Inc. NCIT Stock Holding History

Goldman Sachs’s Portfolio NCIT Stock Details NCIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-24,114
Closed -$509K – 7089
2017
Q2 		$509K Sell
24,114
-4,584
-16% -$78.7K ﹤0.01% 5088
2017
Q1 		$432K Buy
+28,698
New +$403K ﹤0.01% 5154
2016
Q4 		– Sell
-13,713
Closed -$159K – 7250
2016
Q3 		$159K Sell
13,713
-6,146
-31% -$76.8K ﹤0.01% 5972
2016
Q2 		$279K Buy
19,859
+2,840
+17% +$39.1K ﹤0.01% 5405
2016
Q1 		$238K Buy
+17,019
New +$231K ﹤0.01% 5469
2014
Q4 		– Sell
-10,823
Closed -$103K – 7456
2014
Q3 		$103K Sell
10,823
-101
-0.9% -$947 ﹤0.01% 6568
2014
Q2 		$97K Sell
10,924
-13,348
-55% -$129K ﹤0.01% 6563
2014
Q1 		$258K Sell
24,272
-1,290
-5% -$11.9K ﹤0.01% 5850
2013
Q4 		$169K Sell
25,562
-20,109
-44% -$119K ﹤0.01% 6046
2013
Q3 		$257K Sell
45,671
-4,695
-9% -$24K ﹤0.01% 5682
2013
Q2 		$209K Buy
+50,366
New +$227K ﹤0.01% 5559

Goldman Sachs's NCIT Position: Q3 2017 in Review

Goldman Sachs sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 24,114 shares — an estimated $509K sold.

Goldman Sachs first reported a position in NCIT in Q2 2013 and held it in 11 quarters. The position peaked at $509K in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Goldman Sachs reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Goldman Sachs sold 24,114 NCI, Inc. shares in Q3 2017, an estimated $509K.
  • Goldman Sachs first reported a position in NCI, Inc. in Q2 2013 and held it in 11 quarters.
  • Goldman Sachs's NCI, Inc. position peaked at $509K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Goldman Sachs's 13F filing for Q3 2017, filed 14 Nov 2017.